Problem statement: Answer the multiple-choice question.
Query: Which drug exhibits a 10.315\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
a: N#Cc1cnc2sc3ccccc3n2c1=N
b: COc1ccc(C)cc1N(CC(=O)Nc1cccnc1)S(=O)(=O)c1ccc(C)cc1
c: O=C(OCc1ccccc1)c1cccnc1Cl
d: COc1ccccc1/C=C/CN1CCOCC1
Answer: b. COc1ccc(C)cc1N(CC(=O)Nc1cccnc1)S(=O)(=O)c1ccc(C)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccc(C)cc1N(CC(=O)Nc1cccnc1)S(=O)(=O)c1ccc(C)cc1
COc1ccc(C)cc1N(CC(=O)Nc1cccnc1)S(=O)(=O)c1ccc(C)cc1
2-(2-methoxy-5-methyl-N-(4-methylphenyl)sulfonylanilino)-N-pyridin-3-ylacetamide